ドライアイ製品の世界市場（2023年）：2022年～2028年の分析

当レポートでは、世界のドライアイ製品市場について調査し、市場の概要とともに、今後5年間の市場パフォーマンス予測、重要な将来動向、および市場に参入する企業29社の企業プロファイルなどを提供しています。

目次

• ドライアイ疾患の概要
• ドライアイの診断と治療
• ドライアイケアプロバイダーの世界的見解
• 米国、西欧、日本、その他富裕国、中国、インド、ラテンアメリカ、その他の地域の8つの分析カテゴリーにおけるドライアイの現状と5年予測
• 市場におけるドライアイ処方製品
• マイボーム腺発現に使用される器具
• ドライアイ治療に使用される器具と処置
• ドライアイ用OTC製品
• 開発パイプラインにある治験薬
• ドライアイ製品を開発、製造、販売している企業プロファイル

What's New:

The "2023 Dry Eye Products Market Report" now covers more device and pharmaceutical treatment options, including generic, prescription, and over-the-counter. The report features new optometrist survey data, updated disease modeling, and expanded risk factor analysis. The report now forecasts service and handpiece revenue for procedures, when relevant. It profiles 29 market competitors and covers over 100 more companies that participate in this market.

Market Scope's "2023 Dry Eye Products Market Report" analyzes the current marketplace and forecasts market performance through 2028. The report examines dry eye syndrome's etiology, diagnosis, and treatment and provides in-depth coverage on the prevalence of dry eye, prescription therapeutics, over-the-counter lubricants, thermal expression, IPL, punctum plugs, and additional dry eye procedures and products. Product demand is forecast in units and dollars, and market shares are analyzed by product category. Twenty-nine market competitors are profiled, with discussion of their products, strategic market position, background, and outlook.

Contents:

Our report is designed to provide depth and context to the reader's understanding of market dynamics in this ophthalmic segment. Our coverage includes:

• Overview of dry eye disease

• Diagnosis and treatment of dry eye

• A global view of dry eye care providers

• Current estimates and five-year forecasts for dry eye in our eight analytic categories: the United States, Western Europe, Japan, Other Wealthy Nations, China, India, Latin America, and Rest of World.

• Dry eye prescription products in the marketplace

• Instruments used for manual expression of meibomian glands

• Devices and procedures used to treat dry eye

• OTC products for dry eye

• Investigational agents in the development pipeline

• Profiles of companies developing, making, and marketing dry eye products

Author Profile:

William Freeman

Bill Freemanhas more than 35 years of experience developing, manufacturing, and marketing cataract surgery products. He has held key executive positions at four firms that produce ophthalmic surgical devices.

Bill's career in ophthalmology began in the 1970s. As president of Cavitron Surgical Systems, he worked with Dr. Charles Kelman in developing and marketing the world's first phacoemulsifier system. While highly controversial in the 1970s, phacoemulsification gradually became the preferred cataract removal technique in the early 1980s. For many years, Cavitron led the cataract instrumentation market.

CooperVision purchased Cavitron in the early 1980s, and Bill joined the company as president of the surgical division. CooperVision expanded its product line to include a wide variety of cataract surgical products-IOLs, viscoelastic solutions, disposable devices, lasers, and custom packs-and became the market leader in many product categories.

In 1989, Alcon acquired CooperVision in an effort to build a strong presence in cataract surgical devices. Bill joined Alcon as general manager of the Irvine Technology Center, where a number of the company's cataract devices, including the Legacy 20000 phacoemulsifier and a broad line of disposable items, were designed and manufactured.